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Abstract
Background: Hyperbaric oxygen (HBO) therapy has been proved in improving bone healing, but its effects on
mesenchymal stem cells (MSCs) in vivo is not clear. The aims of this study are to clarify whether the HBO therapy
has the same enhancing effect on MSCs with regard to bone formation and maturation and to ascertain whether
the transplanted MSCs survive in the grafted area and contribute to new bone formation.
Methods: Twenty-three adult rabbits underwent posterolateral fusion at L4-L5 level. The animals were divided into
three groups according to the material implanted and subsequent treatment: (1) Alginate carrier (n = 6); (2)
Alginate-MSCs composite (n = 11); and (3) Alginate-MSCs composite with HBO therapy (n = 6). After 12 weeks,
spine fusion was examined using radiographic examination, manual testing, and histological examination. Using a
PKH fluorescence labeling system, whether the transplanted MSCs survived and contributed to new bone
formation in the grafted area after HBO therapy was also examined.
Results: The bilateral fusion areas in each animal were evaluated independently. By radiographic examination and
manual palpation, union for the Alginate, Alginate-MSCs, and Alginate-MSCs-HBO groups was 0 of 12, 10 of 22, and
6 of 12 respectively. The difference between the Alginate-MSCs and Alginate-MSCs-HBO groups was not significant
(P = 0.7997). The fluorescence microscopy histological analysis indicated that the transplanted PKH67-labeled MSCs
survived and partly contributed to new bone formation in the grafted area.
Conclusions: This study demonstrated that the preconditioned MSCs could survive and yield bone formation in
the grafted area. HBO therapy did not enhance the osteogenic ability of MSCs and improve the success of spine
fusion in the rabbit model. Although there was no significant effect of HBO therapy on MSCs for spine fusion, the
study encourages us to research a more basic approach for determining the optimal oxygen tension and pressure
that are required to maintain and enhance the osteogenic ability of preconditioned MSCs. Further controlled in
vivo and in vitro studies are required for achieving a better understanding of the effect of HBO treatment on MSCs.
Background
For posterolateral lumbar fusion, decorticated
transverse processes are generally overlaid with bone
graft materials. In recent decades, investigators have
described various techniques for isolating human and
animal mesenchymal stem cells (MSCs) from the bone
marrow [1-3]. Culturing MSCs with dexamethasone,
ascorbic acid, and b-glycerophosphate directs the cells
into the osteogenic lineage [1,3]. In authors’ pilot
study, the alginate-MSCs (2 × 10
6 cells) composite
successfully formed a bony mass between the
transverse processes in a rabbit model. However,
manual palpation revealed that the consistency of the
bony mass was not solid enough [4].
When alginate-MSCs were laid over the transverse
processes, the transplanted MSCs were exposed to a
temporary avascular environment and oxygen
deprivation. This condition may lead to the cell death or
functional impairment, which can reduce the bone-
forming ability of these cells; however, the precise
effects of oxygen tension on MSCs have not been clearly
established. Some studies have shown that hypoxia had
a negative impact on cell growth and differentiation,
while others had a positive effect on cell proliferation
and osteoblastic differentiation [5-8]. Potier et al.
recently reported that transplanted MSCs subjected to
hypoxia in vivo exhibit a limited angiogenic factor
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osteoblastic markers, which may affect their bone-
forming potential of these cells [9].
Several studies have proved the efficacy of hyperbaric
oxygen (HBO) therapy in improving bone healing or
bone formation. Penttinen et al. found in their study
that the intermittent exposure of rats to HBO for 2 h
d a i l ya t2 . 5a t mr e s u l t e di nh ypertrophy of the cartilage
a n da ni n c r e a s ei nt h er a t eo fb o n ef o r m a t i o n[ 1 0 ] .I n
our previous animal studies, HBO therapy improved
bone healing of tibial lengthening [11,12] and the
success of posterolateral fusion using autogenous iliac
bone graft [13]. Therefore, it would be useful to study
the effects of the HBO therapy on the transplanted
MSCs for bone formation. The purposes of this study
were to (1) document whether the HBO therapy has the
same enhancing effect on MSCs with regard to bone
formation and maturation; (2) ascertain whether the
transplanted MSCs survive in the grafted area and
contribute to new bone formation.
Methods
In this study, 27 male New Zealand rabbits, weighing
3.5 to 4 kg, were used. Approval was obtained from the
Institutional Animal Care and Use Committee at the
institution of the authors prior to the study.
Preparation of MSCs
The methods used for isolation and cultivation of the
rabbit MSCs are as described in our previous study [14].
The rabbits were anesthetized with an intravenous
injection of 5 mL of ketamine hydrochloride (Ketalar,
Parke Davis, Taiwan) and Rompum (Bayer, Leverkusen,
Germany) mixture, 10 mL of bone marrow was
aspirated from the iliac crest under sterile conditions
and was collected into a syringe containing 6000 units
of heparin. The marrow sample was washed with
Dulbecco’s phosphate-buffered saline (DPBS), and
disaggregated by gently passing the sample through a
21-gauge catheter and syringe to obtain a single-cell
suspension. Cells were recovered after centrifugation at
600 × g for 10 min. Up to 2 × 10
8 nucleated cells in 5
mL DPBS were loaded onto a 25 mL Percoll cushion
(Pharmacia Biotech) with a density of 1.073 g/mL in a
50 mL conical tube. Cells were separated by
centrifugation at 1,100 × g for 40 min at 20°C.
Nucleated cells were collected from the interface,
diluted with two volumes of DPBS, and centrifuged at
900 × g. The cells were then resuspended, counted, and
plated at 2 × 10
5 cells/cm
2 in T-75 flasks (Falcon). The
cells were maintained in Dulbecco’s Modified Eagle’s
Medium-Low Glucose (DMEM-LG; Gibco) containing
10% fetal bovine serum (FBS) and antibiotics (100 units/
mL penicillin mixed with 100 μg/mL streptomycin;
Gibco) at 37°C in a humidified atmosphere of 5% CO2
and 95% air. After 4 days of primary culturing,
nonadherent cells were removed by changing the
medium; medium was changed every 3 days thereafter.
The MSCs, which grew as symmetrical colonies, were
subcultured at 10-14 days with 0.05% trypsin and 0.53
mM EDTA for 5 min, rinsed from the substrate with
serum-containing medium, collected by centrifugation at
800 × g for 5 min, and seeded into fresh flasks at 5,000-
6,000 cells/cm
2. Cultures were incubated in a humidified
atmosphere of 5% CO2 and 95% air until cell confluence
was achieved.
Preparation of MSC loaded Alginate (Alginate-MSCs)
Cells were maintained in primary culture until
confluent. Calcium sodium alginate (4.7 cm × 4.7 cm)
(Kaltostat, ConvaTec, UK) was used as a carrier for
mesenchymal stem cells. Approximately 2 × 10
6 MSCs
were seeded on calcium sodium alginate. The Alginate-
MSCs composite was maintained in a 1:1 mixture of the
osteogenic medium (DMEM-LG containing 10% FBS,
antibiotics, 100 μM ascorbate-2-phosphate, 10
-7 M
dexamethasone, and 10 mM b-glycerophosphate) and
incubated at 37°C in a humidified atmosphere of 5%
CO2 and 95% air for one additional week. The medium
was refreshed every 4 days.
Staining with PKH membrane linkers and preparation of
PKH67-labeled MSC loaded Alginate
The rabbit MSCs were isolated, cultured and labeled
with PKH67 membrane linkers (0.5-10 μM, Sigma
Chemical Company, St. Louis, MO). Alginate carriers
were prepared for PKH67 membrane linker-labeled
MSCs. Fluorescent labeling of the MSCs was performed
by incubating 10
7 cells in each 1 mL Diluent C
containing freshly prepared PKH67 membrane linker
(0.5-10 μM, Sigma) for 10 min at room temperature.
The cells were collected by centrifugation (400 × g, 10
min, 4°C), resuspended in Hanks’ balanced salt solution
(HBSS) supplemented with 10% FBS, and washed twice
with HBSS. By using this procedure, 80-90% viable cells
on an average were recovered, as determined by trypan
blue exclusion testing. Approximately 2 × 10
6 PKH67-
labeled MSCs were seeded on calcium alginate (4.7 cm
× 4.7 cm) (Kaltostat, ConvaTec, UK). The Alginate-
PKH67-labeled MSCs composite was then maintained in
a 1:1 mixture of the osteogenic medium and incubated
under conditions identical to those used for the
preparation of the Alginate-MSCs composite.
Animal experiment
The rabbit was anaesthetized via an intravenous
injection of 5 mL of ketamine hydrochloride (Ketalar,
Parke Davis, Taiwan) mixed with Rompum (Bayer,
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prepared with betadine. Under aseptic conditions, a 10-
cm dorsal midline skin incision was made, followed by 2
paramedian fascial incisions to expose the L4 and L5
transverse processes. After decortication of the
transverse processes with an air tome, the Alginate or
Alginate-MSCs composite was deposited between the
transverse processes. The fascia and the skin incisions
were then sutured. The animals were divided into three
groups according to the material implanted and
subsequent treatment: (1) Alginate carrier only; (2)
Alginate-MSCs composite; and (3) Alginate-MSCs
composite with HBO therapy. The rabbits in the HBO
therapy group were treated with 100% oxygen at 2.5
atm for 2 h daily, 5 times a week, while those in the
other groups were maintained under normal room air.
At the end of 12 weeks, the rabbits were sacrificed for
evaluation.
Radiographic analysis
All the animals underwent posteroanterior radiographs
and 2 mm thin-cut computed tomography (CT) scan of
the lumbosacral spine. The bilateral fusion areas in each
animal were evaluated independently. Successful
radiographic union was determined as an uninterrupted
bone bridge between the intertransverse processes. The
CT scans were also evaluated to identify the presence of
bone formation in any unintended areas including the
spinal canal or ventral to the intertransverse process
membrane.
Manual palpation of spine fusion
Following radiography, L3-L6 was excised en block from
the animals. The fusion areas were manipulated with
sufficient force to evaluate the presence of any motion
and avoid causing gross trauma. Only the fusion mass
that was identified as having no gross motion was
considered as successful solid union.
Histological evaluation
The L4-L5 fusion segment was fixed in 10% neutral
buffered formaldehyde, decalcified, dehydrated through
alcohol gradients, cleared and embedded in paraffin
blocks. Tissue blocks were sectioned in the sagittal
plane of the fusion mass included the transverse
processes at 5 μm and stained with hematoxylin and
eosin and Masson trichrome methods. New bone
formation, the interface between the newly formed bone
and the original transverse process, and any
inflammatory response to the carriers were subsequently
assessed.
In situ PKH67-labeled MSCs tracing
In order to ascertain the survival of the transplanted
MSCs, the PKH67-labeled MSCs in the recipients were
directly observed. Specimens harvested from the L4-L5
fusion area were fixed in 2% paraformaldehyde,
decalcified, and embedded in Tissue-Tek O.C.T.
compound. Cryosections (8 μm) were sliced from the
center of the specimens. An Olympus fluorescence
microscope was used to directly examine PKH67-labeled
MSCs in the recipient specimens. RGB image
reconstruction was performed under green fluorescence
under green fluorescence of PKH67-labeled cells.
Statistical analysis
The fusion status of the experimental animals was then
assessed. Differences between the Alginate-MSCs and
Alginate-MSCs-HBO groups were analyzed using chi-
square test with a significant difference assumed at P <
0.05.
Results
Posterolateral intertransverse fusion was performed in a
total of 27 experimental rabbits. The Alginate carrier
only group and Alinate-MSCs group comprised 6 and
11 animals that were extremely tolerant to the surgical
procedures and exhibited no perioperative
complications. Ten rabbits received HBO therapy. Four
animals developed complications and died due to
oxygen intoxication; of these, 1 developed complications
during 5
th HBO treatment; 2, during the 20
th HBO
treatment; and 1, during the 30
th HBO treatment.
Finally, 6 animals that underwent 60 rounds of HBO
treatments were included in this study.
Radiographic analysis
There were 12 fusion areas in the Alginate group, 22 in
the Alginate-MSCs group, and 12 in the Alginate-
MSCs-HBO group, respectively. On plain radiographs
and CT scan images, there was not any bone formation
observed between the transverse processes in the
animals of Alginate group (Figure 1A, B, C, D).
However, 10 of the 22 fusion areas in the Alginate-
M S C sg r o u pw e r ec o n s i d e r e da sr a d i o g r a p h i cu n i o n
compared with 6 of the 12 fusion areas in the
Alginate-MSCs-HBO group (Figure 1I, J, K, L) (P =
0.7997). In the other animals of both groups that no
continuous fusion mass formation was observed on the
plain radiographs, the CT scan images revealed
scattered bone mass formation between the transverse
p r o c e s s e s( F i g u r e1 E ,F ,G ,Ha n dF i g u r e2 ) .N on e w
bone formation occurred in any unintended areas on
the CT scan images.
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Page 3 of 7Figure 1 Results of plain radiographs (A, E, I), dorsal view (B, F, J) and ventral view (C, G, K) 3D CT scan images, and coronary
reconstructive images (D, H, L) in groups of Alginate only and Alginate-MSCs under hyperbaric oxygen (HBO) treatment. A, B, C, D.
The alginate carriers were completely absorbed and there was no bone formation between the transverse processes in the animal implanted
with alginate without mesenchymal stem cells. E, F, G, H. Partial bone formation between the transverse processes in the animal implanted with
Alginate-MSCs after HBO therapy. The scattered and uncalcified bone mass formation without successful fusion was noted. I, J, K, L.A
successful, continuous bone fusion mass with calcification was noted between the transverse processes in the animal implanted with Alginate-
MSCs after HBO therapy. No new bone formation occurred in any unintended areas on the CT scan images.
Figure 2 Results of plain radiographs (A), dorsal view (B) and ventral view (C) 3D CT scan images, and coronary reconstructive images
(D) in groups of Alginate-MSCs without HBO treatment. A successful, continuous bone fusion mass with calcification was noted between
the left intertransverse space. On the contrary, a scattered and uncalcified bone mass without fusion was noted between the right
intertransverse space.
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In the six specimens of Alginate group, the alginate
carriers were absorbed and there was not any bone
formation found. In the other hand, the remnants of the
alginate-MSCs composite were still present in the
specimens of Alginate-MSCs group and the Alginate-
MSCs-HBO group. Manual palpation revealed that a
slight motion between the transverse processes in any
animals considered as radiographic union in both
groups.
Histological evaluation
In the animal specimens from both the Alginate-MSCs
group and the Alginate-MSCs-HBO groups, the alginate
had disintegrated into minute remnants. Bone formation
was present in the graft fragments. There was no
evidence of inflammatory cells or reactions to the
alginate carrier (Figure 3). The specimens of
radiographic union in both groups exhibited bone
formation in the intertransverse interval, but not
interconnected with the recipient transverse process.
The results closely matched the results of manual
palpation.
Histological evaluation for tracing of PKH67-labeled MSCs
in the recipients
PKH67-labeled MSCs were implanted in 4 animals, of
which 2 belonged to the Alginate-MSCs group and 2
to the Alginate-MSCs-HBO group. In all 4 animals,
bone mass formation was observed on the CT scan
images although it was not continuous. The labeled
cells were assessed by fluorescence microscopic
examination and revealed green fluorescent spots in
the grafted area (Figure 4). The findings indicated that
the transplanted MSCs had survived and partly
contributed to new bone formation in the grafted area.
Discussion
Several studies have proved the efficacy of HBO therapy
in improving bone healing or bone formation [10-13],
but the effects HBO therapy on mesenchymal stem cells
in vivo is not clear. This study attempted to (1) clarify
Figure 3 The histological sections of the graft in the animals implanted with Alginate-MSCs composite. A. H&E stains showed new bone
formation was present in the graft fragments and there was no evidence of inflammatory cells or reactions to the alginate carrier (original
magnification ×4). B, C. Masson trichrome stains showed new trabecular bone with collagen-fibril formation (blue areas) in the graft (B, original
magnification ×4; C, original magnification ×10). m = muscle; nb = new bone; al = alginate remnants.
Figure 4 The histological sections of the graft in the animals implanted with PKH67-labeled MSCs after hyperbaric oxygen therapy. A,
B. The examination revealed green fluorescent spots in the grafted area (A, original magnification ×10; B, original magnification ×20). It
indicated that the transplanted MSCs were viable and partly contributed to new bone formation in the grafted area.
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on MSCs with regard to bone formation and
maturation; (2) ascertain whether the transplanted
MSCs survive in the grafted area and contribute to new
bone formation. Using a PKH fluorescence labeling
system, it indicated that the transplanted MSCs survived
in the grafted area and contributed to new bone
formation. However, the final results of the present
study revealed that HBO treatment did not enhance the
preconditioned MSCs with regard to the success of
posterolateral lumbar fusion in a validated rabbit model.
A f t e rb o n eg r a f t i n g ,t h ef o r m a t i o no fn e wb o n ei s
closely associated with the rate of vascularization [15].
In the posterolateral fusion area, the major blood supply
for vascularization of the bone graft was from the upper
and lower transverse processes [16]. After dissection, the
healing environment between the transverse processes is
relatively hypovascular. This hypovascular environment
can result in cell death or functional impairment of the
implanted MSCs, which ultimately affects their bone-
forming ability. HBO is known to accelerate the
development of new blood vessels in hypovascular
tissue, which increases vascularization in the operated
area and enhances bone healing. In the present study,
the reason why HBO did not enhance the osteogenic
potency of the preconditioned MSCs is not quite clear.
It is known that stem cells residing in the bone marrow
are similarly exposed to low oxygen tension [17].
However, the precise effects of oxygen tension on
osteoprogenitor or osteoblast-like cells have not been
clearly established. Some studies have shown that
h y p o x i ah a san e g a t i v ei m p a c to nc e l lg r o w t ha n d
differentiation, whereas others have demonstrated a
positive effect of hypoxia on cell proliferation and
osteoblastic differentiation [5-9]. In the literatures, no
published data is available with regard to the effect of
HBO on MSCs. In the present study, the results of the
histological examination revealed the presence of
PKH67-labeled MSCs in the grafted area. Although the
number of cells was not counted, it indicated that the
implanted MSCs were kept in the alginate carrier and
survived even after the HBO therapy. We supposed that
the phenotype and osteogenic potency of the
preconditioned MSCs might be altered after HBO
therapy. It might be the reason that the HBO therapy
did not have enhancing effect on the bone-forming
potential of MSCs. Further basic studies with regard to
the optimal oxygen tension and pressure required for
the maintenance and enhancement of the osteogenic
ability of preconditioned MSCs need to be carried out.
In order to ascertain the survival of the transplanted
MSCs and to determine whether the new bone had
been derived from the transplanted MSCs, we used the
PKH-67 dye, which was incorporated into cell
membranes and was equally distributed to the daughter
cells during division. The dye is a nonradioactive and
noncytotoxic substance and possesses a fluorescence
h a l f - l i f eo f> 1 0 0d a y si ne r y t h r o c y t e so rM S C s[ 1 8 ] .I n
the current study, bone mass formation was not
continuous and solid in all 4 animals transplanted with
PKH67-labeled MSCs. We did think that the PKH-67
dye would influence the osteogenic ability of MSCs for
spine fusion. However, the fluorescence microscopic
examination revealed green fluorescent spots in the
grafted area (Figure 4). The findings indicated that the
transplanted MSCs had survived and partly contributed
to new bone formation in the grafted area.
The optimal number of MSCs that should be
implanted for achieving successful fusion is a critical
parameter. Minamide et al. reported that implantation
of 1 million bone marrow cells resulted in a poor fusion
rate and that 100 million cells are required to be
implanted for successful posterior spinal fusion in a
rabbit model [19]. Nakajima et al. reported that
implantation of 1.5 million preconditioned cells induced
bone formation and achieved successful posterolateral
fusion in 4 of 5 rabbits. In contrast, only 2 of 6 rabbits
achieved successful fusion when the implanted cells
were not cultured in the osteogenic differentiation
medium [20]. In the current study, we selected 2 million
cells on the basis of the results of our previous study.
The data showed that such a number of preconditioned
MSCs could induce bone formation between the
intertransverse spaces and a low dose (2.5 μg) of
recombinant human bone morphogenetic protein-2
(rhBMP-2) could enhance the osteogenic potency of
MSCs and improves fusion success [4]. In the current
study, we attempted to find some other methods to
improve the osteogenic potency of MSCs. It remains
unclear whether better results will be obtained if a
larger number of cells that have been stimulated with
the HBO are used; however, these findings deserve
further investigation.
A limitation of this study is the insufficient number of
animals that comprised in the HBO treatment group to
a powerful conclusion on the no significant effect of
HBO therapy on MSCs for spine fusion. Due to the
high mortality rate (4 of the 10 animal died) during the
treatment course, we decided not to perform the HBO
therapy on any more animals. This is the reason why
only 6 animals comprised the HBO group. This study,
however, does not discuss the potential risks of the
HBO therapy and only addresses the gross effect of the
HBO therapy on the preconditioned MSCs for
posterolateral fusion. It may, therefore, be of great
interest to determine the effects of the HBO therapy on
the osteogenic potential in MSCs.
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This study demonstrated that the preconditioned MSCs
could survive and yield bone formation in the grafted
area. HBO therapy did not enhance the osteogenic
ability of MSCs and improve the success of spine fusion
in the rabbit model. Although there was no significant
effect of HBO therapy on MSCs for spine fusion, the
study encourages us to research a more basic approach
for determining the optimal oxygen tension and
pressure that are required to maintain and enhance the
osteogenic ability of preconditioned MSCs. Further
controlled in vivo and in vitro studies are required for
achieving a better understanding of the effect of HBO
treatment on MSCs.
Acknowledgements
This work was supported in part by grants received from the National
Science Council of Taiwan, the Republic of China (NSC94-2314-B-182A-046),
and Chang Gung Memorial Hospital, Taiwan.
Authors’ contributions
The following authors have: (1) designed the study: WJC, SWNU, TSF; (2)
carried out all experiments and gathered the data: TSF, TTT, SSL; (3) analyzed
the data: WJC, SWNU, LHC, TTT, SSL, TSF; (4) written the initial draft: TSF, TTT,
SSL; (5) ensured the accuracy of the data and analysis: WJC, SWNU, LHC. All
authors have read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 19 September 2009 Accepted: 19 March 2010
Published: 19 March 2010
References
1. Caplan AI: Mesenchymal stem cells: cell-based reconstructive therapy in
orthopedics. Tissue Engineering 2005, 11:1198-1211.
2. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD,
Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential
of adult human mesenchymal stem cells. Science 1999, 284:143-147.
3. Solchaga LA, Johnstone B, Yoo JU, Goldberg VM, Caplan AI: High variability
in rabbit bone marrow-derived mesenchymal cell preparations. Cell
Transplant 1999, 8:511-519.
4. Fu TS, Chen WJ, Chen LH, Lin SS, Liu SJ, Ueng SW: Enhancement of
posterolateral lumbar spine fusion using low dose rhBMP-2 and cultured
marrow stromal cells. J Orthop Res 2009, 27:380-384.
5. Park JH, Park BH, Kim HK, Park TS, Baek HS: Hypoxia decreases Runx2/
Cbfa1 expression in human osteoblast-like cells. Mol Cell Endocrinol 2002,
192:197-203.
6. Salim A, Nacamuli RP, Morgan EF, Giaccia AJ, Longaker MT: Transient
changes in oxygen tension inhibit osteogenic differentiation and Runx2
expression in osteoblasts. J Biol Chem 2004, 279:40007-40016.
7. Steinbrech DS, Mehrara BJ, Saadeh PB, Chin G, Dudziak ME, Gerrets RP,
Gittes GK, Longaker MT: Hypoxia regulates VEGF expression and cellular
proliferation by osteoblasts in vitro. Plast Reconstr Surg 1999, 104:738-747.
8. Tuncay OC, Ho D, Barker MK: Oxygen tension regulates osteoblast
function. Am J Orthod Dentofac Orthop 1994, 105:457-463.
9. Potier E, Ferreira E, Andriamanalijaona R, Pujol JP, Oudina K, Logeart-
Avramoglou D, Petite H: Hypoxia affects mesenchymal stromal cell
osteogenic differentiation and angiogenic factor expression. Bone 2007,
40:1078-1087.
10. Penttinen R, Niinikoski J, Kulonen E: Hyperbaric oxygen and fracture
healing: a biomechanical study with rats. Acta Chir Scand 1972, 138:39-44.
11. Ueng SW, Lee SS, Lin SS, Wang CR, Liu SJ, Tai CL, Shih CH: Hyperbaric
oxygen therapy mitigates the adverse effect of cigarette smoking on
the bone healing of tibial lengthening: an experimental study on
rabbits. J Trauma 1999, 47:752-759.
12. Ueng SW, Lee SS, Lin SS, Wang CR, Liu SJ, Yang HF, Tai CL, Shih CH: Bone
healing of tibial lengthening is enhanced by hyperbaric oxygen therapy
therapy: a study of bone mineral density and torsional strength on
rabbits. J Trauma 1998, 44:676-681.
13. Chen WJ, Lai PL, Chang CH, Lee MS, Chen CH, Tai CL: The effect of
hyperbaric oxygen therapy on spinal fusion: using the model of
posterolateral intertransverse fusion in rabbits. J Trauma 2002,
52:333-338.
14. Ueng SW, Lee MS, Lin SS, Chan EC, Liu SJ: Development of a
biodegradable alginate carrier system for antibiotics and bone cells. J
Orthop Res 2007, 25:62-72.
15. Kirkeby OJ: Revascularization of bone grafts in rats. J Bone Joint Surg (B)
1991, 73:501-505.
16. Toribatake Y, Hutton WC, Tomita K, Boden SD: Vascularization of the
fusion mass in a posterolateral intertransverse process fusion. Spine 1998,
23:1149-1154.
17. Fink T, Abildtrup L, Fogd K, Abdallah BM, Kassem M, Ebbesen P, Zachar V:
Induction of adipocyte-like phenotype in human mesenchymal stem
cells by hypoxia. Stem Cells 2004, 22:1346-1355.
18. Askenasy N, Farkas DL: Optical imaging of PKH labeled hematopoietic
cells in recipient bone marrow in vivo. Stem Cell 2002, 20:501-513.
19. Minamide A, Yoshida M, Kawakami M, Yamasaki S, Kojima H, Hashizume H,
Boden SD: The use of cultured bone marrow cells in type I collagen gel
and porous hydroxyapatite for posterolateral lumbar spine fusion. Spine
2005, 30:1134-1138.
20. Nakajima T, Lizuka H, Tsutsumi S, Kayakabe M, Takagishi K: Evaluation of
posterolateral spinal fusion using mesenchymal stem cells: differences
with or without osteogenic differentiation. Spine 2007, 32:2432-2436.
Pre-publication history
The pre-publication history for this paper can be accessed here: http://www.
biomedcentral.com/1471-2474/11/52/prepub
doi:10.1186/1471-2474-11-52
Cite this article as: Fu et al.: Effect of hyperbaric oxygen on
mesenchymal stem cells for lumbar fusion in vivo. BMC Musculoskeletal
Disorders 2010 11:52.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Fu et al. BMC Musculoskeletal Disorders 2010, 11:52
http://www.biomedcentral.com/1471-2474/11/52
Page 7 of 7